NCT00601692View on ClinicalTrials.gov

Irinotecan, Radiation Therapy, and Docetaxel With or Without Cisplatin in Treating Patients With Locally Advanced Esophageal Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

April 30, 2003

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions
Esophageal Cancer
Interventions
DRUG

cisplatin

Given IV

DRUG

docetaxel

Given IV

DRUG

irinotecan hydrochloride

Given IV

RADIATION

radiation therapy

Given 5 days a week for 3 weeks

Trial Locations (1)

10065

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00601692 - Irinotecan, Radiation Therapy, and Docetaxel With or Without Cisplatin in Treating Patients With Locally Advanced Esophageal Cancer | Biotech Hunter | Biotech Hunter